Clover Health Investments... (CLOV)
NASDAQ: CLOV
· Real-Time Price · USD
2.52
-0.09 (-3.45%)
At close: Aug 19, 2025, 3:59 PM
2.55
0.99%
After-hours: Aug 19, 2025, 07:59 PM EDT
-3.45% (1D)
Bid | 1.88 |
Market Cap | 1.29B |
Revenue (ttm) | 1.61B |
Net Income (ttm) | -43.1M |
EPS (ttm) | -0.08 |
PE Ratio (ttm) | -31.56 |
Forward PE | n/a |
Analyst | Buy |
Ask | 3.21 |
Volume | 7,846,084 |
Avg. Volume (20D) | 9,404,345 |
Open | 2.61 |
Previous Close | 2.61 |
Day's Range | 2.47 - 2.63 |
52-Week Range | 2.12 - 4.87 |
Beta | 1.92 |
About CLOV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLOV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLOV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Clover Health Investments Corp. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-20.7%
Clover Health Investments shares are trading lower...
Unlock content with
Pro Subscription
3 months ago
+12.54%
Clover Health Investments shares are trading higher. The company reported Q1 financial results.

2 weeks ago · fool.com
Clover Health (CLOV) Q2 Sales Up 34%Clover Health (CLOV) Q2 Sales Up 34%

2 weeks ago · seekingalpha.com
Clover Health Investments, Corp. (CLOV) Q2 2025 Earnings Call TranscriptClover Health Investments, Corp. (NASDAQ:CLOV ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Andrew Toy - Co-Founder, CEO & Director Peter J. Kuipers - Chief Financi...